{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T16:04:23Z","timestamp":1740153863815,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T00:00:00Z","timestamp":1639353600000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gut Pathog"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>There are several studies which evaluated the number of infections caused by enteric pathogens, including <jats:italic>Clostridioides difficile<\/jats:italic> in patients with inflammatory bowel disease (IBD). Our aim was to assess the prevalence of intestinal infections among patients suffering from IBD, when admitted to the hospital due to exacerbation of the disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The performed, retrospective analysis covered test results for <jats:italic>C. difficile<\/jats:italic> toxins A and B along with rectal swab cultures sampled from patients, treated in a tertiary IBD center in Poland, between 2017 and 2019. Main objective was to estimate the presence of any infection, which could imitate or co-exist along with the exacerbation of the IBD. All in all 1471 patients had microbiological tests performed, including 1112 tested for <jats:italic>C. difficile<\/jats:italic> toxins A and B; and 359 patients who had rectal swab culture. Positive test results for <jats:italic>C. difficile<\/jats:italic> toxins A and B were reported in 358 cases, positive results from rectal swab culture were confirmed altogether in case of 25 samples. As far as patients with IBD are concerned, positive results for <jats:italic>C. difficile<\/jats:italic> toxins A and B were detected in 82 cases, positive results in rectal swab culture from patients with IBD were reported in 20 cases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Intestinal infections were reported in 14.9% of patients (102\/685) with IBD symptoms. Positive test results for <jats:italic>C. difficile<\/jats:italic> toxins A and B and rectal swab cultures among patients without IBD symptoms were reported in 35.7% of cases (281\/786). Intestinal superinfections may complicate the clinical picture of IBD patients, increasing the diagnostic and therapeutic burden. Appropriate early procedures are thus needed in these patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13099-021-00471-z","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T13:03:10Z","timestamp":1639400590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Retrospective analysis of Clostridioides difficile and other intestinal infections in patients with Crohn\u2019s disease and ulcerative colitis in the tertiary hospital in Poland. POLIBD survey results"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1390-9278","authenticated-orcid":false,"given":"Jolanta","family":"Gruszecka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafa\u0142","family":"Filip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,13]]},"reference":[{"issue":"4","key":"471_CR1","first-page":"244","volume":"19","author":"P Mo\u0107ko","year":"2016","unstructured":"Mo\u0107ko P, Kawalec P, Pilc A. Inflammatory bowel diseases (IBD) as public health problem\u2014review of the literatur\u0119. Med Rodz. 2016;19(4):244\u201354.","journal-title":"Med Rodz"},{"issue":"3","key":"471_CR2","first-page":"141","volume":"9","author":"S Badurek","year":"2016","unstructured":"Badurek S, Muszytowski M, Str\u00f3\u017cecki P, Manitius J. Clostridium difficile-associated disease in patients with chronic kidney disease. Forum Nefrol. 2016;9(3):141\u20138.","journal-title":"Forum Nefrol"},{"key":"471_CR3","first-page":"129","volume-title":"Medical microbiology","author":"G Martirosian","year":"2014","unstructured":"Martirosian G. Laseczki Gram-dodatnie wytwarzaj\u0105ce spory\/gram-positive bacilli that produce spores. In: Heczko PB, Wr\u00f3blewska M, Pietrzyk A, editors. Medical microbiology. Warsaw: PZWL (National Institute of Medical Publications); 2014. p. 129\u201336."},{"issue":"1","key":"471_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/ng.2478","volume":"45","author":"M He","year":"2013","unstructured":"He M, Miyajima F, Roberts P, et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet. 2013;45(1):109\u201313. https:\/\/doi.org\/10.1038\/ng.2478.","journal-title":"Nat Genet"},{"issue":"5","key":"471_CR5","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.cmi.2017.12.005","volume":"24","author":"C Gateau","year":"2018","unstructured":"Gateau C, Couturier J, Coia J, Barbut F. How to: diagnose infection caused by Clostridium difficile. Clin Microbiol Infect. 2018;24(5):463\u20138. https:\/\/doi.org\/10.1016\/j.cmi.2017.12.005.","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"471_CR6","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/01.meg.0000131040.38607.09","volume":"16","author":"M Mylonaki","year":"2004","unstructured":"Mylonaki M, Langmead L, Pantes A, et al. Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Eur J Gastroenterol Hepatol. 2004;16(8):775\u20138.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"471_CR7","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1093\/ibd\/izy086","volume":"24","author":"EB Grant","year":"2018","unstructured":"Grant EB, Hendler S, Okafor P, et al. Rising incidence of intestinal infections in inflammatory bowel disease: a nationwide analysis. Inflamm Bowel Dis. 2018;24(8):1849\u201356.","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"471_CR8","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1038\/s41395-018-0211-8","volume":"113","author":"EA Jordan","year":"2018","unstructured":"Jordan EA, Joelson A, Green P, et al. Enteric infections are common in patients with flares of inflammatory bowel disease. Am J Gastroenterol. 2018;113(10):1530\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"471_CR9","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.cgh.2018.09.034","volume":"17","author":"JE Axelrad","year":"2019","unstructured":"Axelrad JE, Ol\u00e9n O, Askling J, et al. Gastrointestinal infection increases odds of inflammatory bowel disease in a nationwide case-control study. Clin Gastroenterol Hepatol. 2019;17(7):1311\u201322.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"471_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.crohns.2009.02.010","volume":"3","author":"JF Rahier","year":"2009","unstructured":"Rahier JF, Ben-Horin S, Chowers Y, et al. European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2009;3:46\u201391.","journal-title":"J Crohns Colitis"},{"key":"471_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000212076","volume":"80","author":"M Navarro-Llavat","year":"2009","unstructured":"Navarro-Llavat M, Dom\u00e8nech E, Bernal I, et al. Prospective, observational, cross-sectional study of intestinal infections among acutely active inflammatory bowel disease patients. Digestion. 2009;80:25\u20139.","journal-title":"Digestion"},{"key":"471_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12876-018-0920-x","volume":"19","author":"H Xu","year":"2019","unstructured":"Xu H, Tang H, Xu T, et al. Retrospective analysis of Clostridium difficile infection in patients with ulcerative colitis in a tertiary hospital in China. BMC Gastroenterol. 2019;19:3.","journal-title":"BMC Gastroenterol"},{"key":"471_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/PAT.0b013e328358343c","author":"P Harris","year":"2012","unstructured":"Harris P, Vinney J, Ashhurst-Smith C, et al. Comparison of Vitek MS (MALDI-TOF) to standard routine identification methods: an advance but no panacea. Pathology. 2012. https:\/\/doi.org\/10.1097\/PAT.0b013e328358343c.","journal-title":"Pathology"},{"issue":"11","key":"471_CR14","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1128\/JCM.00403-07","volume":"45","author":"MA Pfaller","year":"2007","unstructured":"Pfaller MA, Diekeman DJ, Procop GW, et al. Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp. J Clin Mikrobiol. 2007;45(11):3522\u20138.","journal-title":"J Clin Mikrobiol"},{"issue":"6","key":"471_CR15","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1111\/j.1572-0241.2007.01780.x","volume":"103","author":"GC Nguyen","year":"2008","unstructured":"Nguyen GC, Kaplan GG, Harris ML, et al. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103(6):1443\u201350.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"471_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cgh.2006.12.028","volume":"5","author":"M Issa","year":"2007","unstructured":"Issa M, Vijayapal A, Graham MB, Beaulieu DB, et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5(3):345\u201351.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"471_CR17","first-page":"287","volume":"373","author":"DA Leffler","year":"2015","unstructured":"Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med. 2015;373(3):287\u20138.","journal-title":"N Engl J Med"},{"key":"471_CR18","unstructured":"Zi\u00f3\u0142kowski G, Zi\u00f3\u0142kowska B, Ochocka B. Infekcje Clostridium difficile, niedoceniane zaka\u017cenia w aspekcie klinicznym i epidemiologicznym\/Clostridium difficile infections, underestimated infections in the clinical and epidemiological aspect. Polskie Stowarzyszenie Piel\u0119gniarek Epidemiologicznych\/Polish Association of Epidemiological Nurses, Katowice; 2012."},{"issue":"1","key":"471_CR19","first-page":"22","volume":"9","author":"P Albrecht","year":"2013","unstructured":"Albrecht P, Pituch H. Clostridium difficile\u2014a growing diagnostic and therapeutic problem. Onkol Prak Klin. 2013;9(1):22\u201331.","journal-title":"Onkol Prak Klin"},{"issue":"33","key":"471_CR20","doi-asserted-by":"publisher","first-page":"11736","DOI":"10.3748\/wjg.v20.i33.11736","volume":"20","author":"A Trifan","year":"2014","unstructured":"Trifan A, Stanciu C, Stoica O, et al. Impact of Clostridium difficile infection on inflammatory bowel disease outcome: a review. World J Gastroenterol. 2014;20(33):11736\u201342.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"471_CR21","first-page":"125","volume":"9","author":"J Czepiel","year":"2014","unstructured":"Czepiel J, Biesiada G, Perucki W, et al. Clostridium difficile infection in patients with inflammatory bowel disease. Prz Gastroenterol. 2014;9(3):125\u20139.","journal-title":"Prz Gastroenterol"},{"key":"471_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.diagmicrobio.2012.06.012","volume":"73","author":"N Azie","year":"2012","unstructured":"Azie N, Neofytos D, Pfaller M, et al. The PATH (prospective antifungal therapy) alliance registry and invasive fungal infections: update 2012. Diagn Microbiol Infect Dis. 2012;73:293\u2013300.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"471_CR23","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/ajg.2012.218","volume":"107","author":"GR Lichtenstein","year":"2012","unstructured":"Lichtenstein GR, Feagan BG, Cohen RD, et al. Serious infection and mortality in patients with Crohn\u2019s disease: more than 5 years of follow-up in the TREAT registry. Am J Gastroenterol. 2012;107:1409\u201322.","journal-title":"Am J Gastroenterol"},{"key":"471_CR24","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1053\/j.gastro.2008.01.012","volume":"134","author":"M Toruner","year":"2008","unstructured":"Toruner M, Loftus EV, Harmsen WS, et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterol. 2008;134:929\u201336.","journal-title":"Gastroenterol"},{"key":"471_CR25","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0140-6736(08)61199-X","volume":"372","author":"MA Park","year":"2008","unstructured":"Park MA, Li JT, Hagan JB, et al. Common variable immunodeficiency: a new look at an old disease. Lancet. 2008;372:489\u2013502.","journal-title":"Lancet"},{"key":"471_CR26","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1056\/NEJMcp051203","volume":"353","author":"M Scott","year":"2005","unstructured":"Scott M, Hammer SM. Management of newly diagnosed HIV infection. N Engl J Med. 2005;353:1702\u201310.","journal-title":"N Engl J Med"},{"key":"471_CR27","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/MIB.0b013e3182a827d2","volume":"20","author":"M Dave","year":"2014","unstructured":"Dave M, Purohit T, Razonable R, et al. Opportunistic infections due to inflammatory bowel disease therapy. Inflamm Bowel Dis. 2014;20:196\u2013212.","journal-title":"Inflamm Bowel Dis"},{"key":"471_CR28","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.crohns.2011.07.012","volume":"6","author":"E Antonelli","year":"2012","unstructured":"Antonelli E, Baldoni M, Giovenali P, et al. Intestinal superinfections in patients with inflammatory bowel diseases. J Crohns Colitis. 2012;6:154\u20139.","journal-title":"J Crohns Colitis"},{"key":"471_CR29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1053\/j.gastro.2018.04.012","volume":"155","author":"J Kirchgesner","year":"2018","unstructured":"Kirchgesner J, Lemaitre M, Carrat F, et al. Risk of serious and opportunistic infections associated with treatment of inflammatory bowel diseases. Gastroenterology. 2018;155:337\u201346.","journal-title":"Gastroenterology"},{"key":"471_CR30","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.crohns.2013.12.013","volume":"8","author":"JF Rahier","year":"2014","unstructured":"Rahier JF, Magro F, Abreu C, et al. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2014;8:443\u201368.","journal-title":"J Crohns Colitis"},{"issue":"1","key":"471_CR31","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1186\/s12879-016-1786-6","volume":"16","author":"S Zhang","year":"2016","unstructured":"Zhang S, Palazuelos-Munoz S, Balsells EM, et al. Cost of hospital management of Clostridium difficile infection in United States\u2014a meta-analysis and modelling study. BMC Infect Dis. 2016;16(1):447.","journal-title":"BMC Infect Dis"},{"key":"471_CR32","doi-asserted-by":"publisher","DOI":"10.26444\/aaem\/119321","author":"Z Kiersnowska","year":"2020","unstructured":"Kiersnowska Z, Lemiech-Mirowska E, Ginter-Kramarczyk D, et al. Problems of Clostridium difficile infection (CDI) in Polish healthcare units. Ann Agric Environ Med. 2020. https:\/\/doi.org\/10.26444\/aaem\/119321.","journal-title":"Ann Agric Environ Med"},{"key":"471_CR33","unstructured":"National Institute Of Public Health (NIZP-PZH) reports on cases of infectious diseases and poisonings in Poland http:\/\/wwwold.pzh.gov.pl\/oldpage\/epimeld\/index_p.html. Accessed 15 Jan 2021."},{"issue":"2","key":"471_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jhin.2015.06.017","volume":"91","author":"A Le Monnier","year":"2015","unstructured":"Le Monnier A, Duburcq A, Zahar JR, et al. Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals. J Hosp Infect. 2015;91(2):117\u201322.","journal-title":"J Hosp Infect"},{"issue":"22","key":"471_CR35","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1001\/jamainternmed.2013.9763","volume":"173","author":"E Zimlichman","year":"2013","unstructured":"Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173(22):2039\u201346.","journal-title":"JAMA Intern Med"},{"key":"471_CR36","doi-asserted-by":"publisher","first-page":"264","DOI":"10.4103\/0255-0857.99482","volume":"30","author":"S Ahmad","year":"2012","unstructured":"Ahmad S, Khan Z. Invasive candidiasis: a review of nonculture-based laboratory diagnostic methods. Indian J Med Microbiol. 2012;30:264\u20139.","journal-title":"Indian J Med Microbiol"},{"key":"471_CR37","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1002\/jmv.21877","volume":"82","author":"N L\u00e9v\u00eaque","year":"2010","unstructured":"L\u00e9v\u00eaque N, Brixi-Benmansour H, Reig T, et al. Low frequency of cytomegalovirus infection during exacerbations of inflammatory bowel diseases. J Med Virol. 2010;82:1694\u2013700.","journal-title":"J Med Virol"}],"container-title":["Gut Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-021-00471-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13099-021-00471-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-021-00471-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T13:04:56Z","timestamp":1639400696000},"score":1,"resource":{"primary":{"URL":"https:\/\/gutpathogens.biomedcentral.com\/articles\/10.1186\/s13099-021-00471-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["471"],"URL":"https:\/\/doi.org\/10.1186\/s13099-021-00471-z","relation":{},"ISSN":["1757-4749"],"issn-type":[{"type":"electronic","value":"1757-4749"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"29 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Bioethics Committee of the Regional Medical Chamber (Resolution No. 88\/B\/2020 of September 24, 2020). As only retrospective studies were performed, according to Polish law, patient consent was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}